Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation

Intensive Care Medicine

Volumn 41, Issue 1, 2015, Pages 1-11

  Forel, Jean Marie ^a,b   Guervilly, Christophe ^b   Hraiech, Sami ^a,b   Voillet, François ^b   Thomas, Guillemette ^a,b   Somma, Claude ^a   Secq, Véronique ^a,b   Farnarier, Catherine ^c   Payan, Marie Josée ^a,b   Donati, Stéphanie Yannis ^d   Perrin, Gilles ^e   Trousse, Delphine ^b   Dizier, Stéphanie ^b   Chiche, Laurent ^a,b   Baumstarck, Karine ^f   Roch, Antoine ^a,b   Papazian, Laurent ^a,b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d hôpital Sainte Musse   (France)

^e TIMONE HOSPITAL   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Accuracy; Biopsy; Comparative; Sensitivity

Indexed keywords

CORTICOSTEROID; N TERMINAL PEPTIDE TYPE III PROCOLLAGEN; PROCOLLAGEN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; COLLAGEN TYPE 3; GLUCOCORTICOID;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; LUNG BIOPSY; LUNG DISEASE; LUNG FIBROPROLIFERATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CARE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VENTILATED PATIENT; BIOPSY; CHEMISTRY; COMPLICATION; FIBROBLAST; METABOLISM; MIDDLE AGED; PATHOLOGY; PULMONARY FIBROSIS;

AGED; BIOLOGICAL MARKERS; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN TYPE III; FEMALE; FIBROBLASTS; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84917743754     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3524-0     Document Type: Article

References (36)

1. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
2. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349
3. Tonelli AR, Zein J, Adams J, Ioannidis JP (2014) Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses. Intensive Care Med 40:769–787
4. Wang CY, Calfee CS, Paul DW, Janz DR, May AK, Zhuo H, Bernard GR, Matthay MA, Ware LB, Kangelaris KN (2014) One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensive Care Med 40:388–396
5. Dos Santos CC (2008) Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med 34:619–630
6. Anderson WR, Thielen K (1992) Correlative study of adult respiratory distress syndrome by light, scanning, and transmission electron microscopy. Ultrastruct Pathol 16:615–628
7. Martin C, Papazian L, Payan MJ, Saux P, Gouin F (1995) Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest 107:196–200
8. Meduri GU, Marik PE, Chrousos GP, Pastores SM, Arlt W, Beishuizen A, Bokhari F, Zaloga G, Annane D (2008) Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 34:61–69
9. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280:159–165
10. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684
11. Papazian L, Doddoli C, Chetaille B, Gernez Y, Thirion X, Roch A, Donati Y, Bonnety M, Zandotti C, Thomas P (2007) A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 35:755–762
12. Kivirikko KI, Myllyla R (1985) Post-translational processing of procollagens. Ann N Y Acad Sci 460:187–201
13. Gonzalez-Lopez A, Garcia-Prieto E, Batalla-Solis E, Amado-Rodriguez L, Avello N, Blanch L, Albaiceta GM (2012) Lung strain and biological response in mechanically ventilated patients. Intensive Care Med 38:240–247
14. Clark JG, Milberg JA, Steinberg KP, Hudson LD (1995) Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 122:17–23
15. Chesnutt AN, Matthay MA, Tibayan FA, Clark JG (1997) Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 156:840–845
16. Farjanel J, Hartmann DJ, Guidet B, Luquel L, Offenstadt G (1993) Four markers of collagen metabolism as possible indicators of disease in the adult respiratory distress syndrome. Am Rev Respir Dis 147:1091–1099
17. Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307:2526–2533
18. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Slutsky AS, Vincent JL, Rubenfeld GD, Thompson BT, Ranieri VM (2012) The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 38:1573–1582
19. STARD (2008) http://www.stard-statement.org/. Accessed 25 August 2014
20. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843
21. Dean AG, Sullivan KM, Soe MM (2014) OpenEpi: Open Source Epidemiologic Statistics for Public Health. http://www.openepi.com/Menu/OE_Menu.htm. Accessed 26 June 2013
22. Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857–872
23. Simel DL, Samsa GP, Matchar DB (1991) Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44:763–770
24. Shahzeidi S, Mulier B, de Crombrugghe B, Jeffery PK, McAnulty RJ, Laurent GJ (1993) Enhanced type III collagen gene expression during bleomycin induced lung fibrosis. Thorax 48:622–628
25. Watanabe Y, Yamaki K, Yamakawa I, Takagi K, Satake T (1985) Type III procollagen N-terminal peptides in experimental pulmonary fibrosis and human respiratory diseases. Eur J Respir Dis 67:10–16
26. Bjermer L, Lundgren R, Hallgren R (1989) Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 44:126–131
27. Low RB, Giancola MS, King TE Jr, Chapitis J, Vacek P, Davis GS (1992) Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am Rev Respir Dis 146:701–706
28. Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ, Laurent GJ (2000) Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 162:1783–1788
29. Demoule A, Decailliot F, Jonson B, Christov C, Maitre B, Touqui L, Brochard L, Delclaux C (2006) Relationship between pressure-volume curve and markers for collagen turn-over in early acute respiratory distress syndrome. Intensive Care Med 32:413–420
30. Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A (1998) Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 158:1432–1441
31. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131:954–963
32. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, Vincent F, Gruson D, Bruneel F, Epinette-Branche G, Lafabrie A, Hamidfar-Roy R, Cracco C, Renard B, Tonnelier JM, Blot F, Chevret S, Schlemmer B (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038–1046
33. Berger P, Papazian L, Drancourt M, La Scola B, Auffray JP, Raoult D (2006) Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg Infect Dis 12:248–255
34. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
35. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
36. Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138:720–723